Research Article| Volume 43, ISSUE 12, P2277-2284, December 2017

Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores

Published:September 04, 2017DOI:



      Recently, there has been increasing interest in the preoperative prediction and prevention of post-hepatectomy liver failure (PHLF). This is a particular concern in colorectal liver metastases (CRLM), when surgery follows potentially hepatotoxic chemotherapy. Platelet-based liver scores (PBLS) such as APRI and FIB-4 are predictive of chemotherapy-associated liver injury (CALI) and PHLF. Estimation of the future liver remnant function (eFLRF) by combining 99mTc-Mebrofenin Hepatobiliary Scintigraphy (HBSBSA) with future liver remnant volume ratio (FLRV%), is predictive of PHLF and related mortality. We hypothesized that a HBSBSA based formula was a better predictor for PHLF than PBLS in chemotherapy-pretreated CRLM.


      Between 2012 and 2016, 140 patients underwent liver resection for CRLM following systemic therapy. HBSBSA, FLRV%, eFLRF and PBLS were calculated and compared for their value in predicting PHLF.


      eFLRF and FLRV% had a better predictive value for PHLF than HBSBSA alone and APRI and FIB-4 (AUC = 0.800, 0.843 versus 0.652, 0.635 and 0.658 respectively). In a subgroup analysis (Oxaliplatin all, Oxaliplatin ≥ 6 cycles, Irinotecan all and Irinotecan ≥ 6 cycles), eFLRF was the only factor predictive for PHLF in all subgroups (all: p ≤ 0.05). Prediction of HBSBSA for chemotherapy associated steato-hepatitis (CASH) reached almost significance (p = 0.06). FIB-4 was predictive for sinusoidal obstruction syndrome (SOS) (p = 0.011). Only weak correlation was found between HBSBSA and PBLS.


      eFLRF is a better predictor of PHLF than PBLS or HBSBSA alone. PBLS seem to measure other aspects of liver function or damage than HBSBSA.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rubbia-Brandt L.
        • Audard V.
        • Sartoretti P.
        • Roth A.D.
        • Brezault C.
        • Le Charpentier M.
        • et al.
        Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
        Ann Oncol. 2004; 15: 460-466
        • Ratti F.
        • Cipriani F.
        • Catena M.
        • Paganelli M.
        • Aldrighetti L.
        Liver failure in patients treated with chemotherapy for colorectal liver metastases: role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysis.
        Eur J Surg Oncol. 2014; 40: 1550-1556
        • Bennink R.J.
        • Dinant S.
        • Erdogan D.
        • Heijnen B.H.
        • Straatsburg I.H.
        • van Vliet A.K.
        • et al.
        Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy.
        J Nucl Med. 2004; 45: 965-971
        • Erdogan D.
        • Heijnen B.H.
        • Bennink R.J.
        • Kok M.
        • Dinant S.
        • Straatsburg I.H.
        • et al.
        Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.
        Liver Int. 2004; 24: 117-123
        • Chapelle T.
        • Op De Beeck B.
        • Huyghe I.
        • Francque S.
        • Driessen A.
        • Roeyen G.
        • et al.
        Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?.
        HPB (Oxf). 2016; 18: 494-503
        • Chapelle T.
        • Op de Beeck B.
        • Roeyen G.
        • Bracke B.
        • Hartman V.
        • De Greef K.
        • et al.
        Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study.
        HPB (Oxf). 2017; 19: 108-117
        • Ekman M.
        • Fjalling M.
        • Holmberg S.
        • Person H.
        IODIDA clearance rate: a method for measuring hepatocyte uptake function.
        Transpl Proc. 1992; 24: 387-388
        • Vreuls C.P.
        • Van Den Broek M.A.
        • Winstanley A.
        • Koek G.H.
        • Wisse E.
        • Dejong C.H.
        • et al.
        Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
        Histopathology. 2012; 61: 314-318
        • Rahbari N.N.
        • Garden O.J.
        • Padbury R.
        • Brooke-Smith M.
        • Crawford M.
        • Adam R.
        • et al.
        Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS).
        Surgery. 2011; 149: 713-724
        • Shindoh J.
        • Tzeng C.W.
        • Aloia T.A.
        • Curley S.A.
        • Zimmitti G.
        • Wei S.H.
        • et al.
        Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.
        Ann Surg Oncol. 2013; 20: 2493-2500
        • Wolf P.S.
        • Park J.O.
        • Bao F.
        • Allen P.J.
        • DeMatteo R.P.
        • Fong Y.
        • et al.
        Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
        J Am Coll Surg. 2013; 216: 41-49
        • Tani K.
        • Shindoh J.
        • Takamoto T.
        • Shibahara J.
        • Nishioka Y.
        • Hashimoto T.
        • et al.
        Kinetic changes in liver parenchyma after preoperative chemotherapy for patients with colorectal liver metastases.
        J Gastrointest Surg. 2017; 21: 813-821
        • Vauthey J.N.
        • Pawlik T.M.
        • Ribero D.
        • Wu T.T.
        • Zorzi D.
        • Hoff P.M.
        • et al.
        Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
        J Clin Oncol. 2006; 24: 2065-2072
        • Robinson S.M.
        • Wilson C.H.
        • Burt A.D.
        • Manas D.M.
        • White S.A.
        Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis.
        Ann Surg Oncol. 2012; 19: 4287-4299
        • Nakano H.
        • Oussoultzoglou E.
        • Rosso E.
        • Casnedi S.
        • Chenard-Neu M.P.
        • Dufour P.
        • et al.
        Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
        Ann Surg. 2008; 247: 118-124
        • Kishi Y.
        • Zorzi D.
        • Contreras C.M.
        • Maru D.M.
        • Kopetz S.
        • Ribero D.
        • et al.
        Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.
        Ann Surg Oncol. 2010; 17: 2870-2876
        • Wai C.T.
        • Greenson J.K.
        • Fontana R.J.
        • Kalbfleisch J.D.
        • Marrero J.A.
        • Conjeevaram H.S.
        • et al.
        A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
        Hepatology. 2003; 38: 518-526
        • Cheng J.
        • Zhao P.
        • Liu J.
        • Liu X.
        • Wu X.
        Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.
        Med (Baltim). 2016; 95e5486
        • Soubrane O.
        • Brouquet A.
        • Zalinski S.
        • Terris B.
        • Brezault C.
        • Mallet V.
        • et al.
        Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
        Ann Surg. 2010; 251: 454-460
        • Vigano L.
        • Rubbia-Brandt L.
        • Rosa G.
        • Majno P.
        • Langella S.
        • Toso C.
        • et al.
        Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact.
        Ann Surg Oncol. 2015; 22: 4149-4157
        • Sterling R.K.
        • Lissen E.
        • Clumeck N.
        • Sola R.
        • Correa M.C.
        • Montaner J.
        • et al.
        Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
        Hepatology. 2006; 43: 1317-1325
        • Vallet-Pichard A.
        • Mallet V.
        • Nalpas B.
        • Verkarre V.
        • Nalpas A.
        • Dhalluin-Venier V.
        • et al.
        FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
        Hepatology. 2007; 46: 32-36
        • Dong J.
        • Xu X.H.
        • Ke M.Y.
        • Xiang J.X.
        • Liu W.Y.
        • Liu X.M.
        • et al.
        The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the Milan criteria.
        Eur J Surg Oncol. 2016; 42: 722-727
        • Hubert C.
        • Sempoux C.
        • Humblet Y.
        • van den Eynde M.
        • Zech F.
        • Leclercq I.
        • et al.
        Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.
        HPB. 2013; 15: 858-864
        • Krishnamurthy S.
        • Krishnamurthy G.T.
        Technetium-99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology.
        Hepatology. 1989; 9: 139-153
        • de Graaf W.
        • van Lienden K.P.
        • Dinant S.
        • Roelofs J.J.
        • Busch O.R.
        • Gouma D.J.
        • et al.
        Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.
        J Gastrointest Surg. 2010; 14: 369-378
        • Dinant S.
        • de Graaf W.
        • Verwer B.J.
        • Bennink R.J.
        • van Lienden K.P.
        • Gouma D.J.
        • et al.
        Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry.
        J Nucl Med. 2007; 48: 685-692
        • de Graaf W.
        • Vetelainen R.L.
        • de Bruin K.
        • van Vliet A.K.
        • van Gulik T.M.
        • Bennink R.J.
        99mTc-GSA scintigraphy with SPECT for assessment of hepatic function and functional volume during liver regeneration in a rat model of partial hepatectomy.
        J Nucl Med. 2008; 49: 122-128
        • de Graaf W.
        • van Lienden K.P.
        • van Gulik T.M.
        • Bennink R.J.
        (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.
        J Nucl Med. 2010; 51: 229-236
        • Cieslak K.P.
        • Bennink R.J.
        • de Graaf W.
        • van Lienden K.P.
        • Besselink M.G.
        • Busch O.R.
        • et al.
        Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.
        HPB (Oxf). 2016; 18: 773-780